We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$504B
AUM Growth
+$5.92B
Cap. Flow
-$3.19B
Cap. Flow %
-0.63%
Top 10 Hldgs %
16.49%
Holding
2,620
New
96
Increased
950
Reduced
1,023
Closed
72

Top Buys

Rank Stock Value
1
WFC icon
Wells Fargo
WFC
+$1.31B
2
HD icon
Home Depot
HD
+$1.07B
3
BABA icon
Alibaba
BABA
+$1.06B
4
YUM icon
Yum! Brands
YUM
+$887M
5
HON icon
Honeywell
HON
+$860M

Top Sells

Rank Stock Value
1
N
Netsuite Inc
N
+$1.59B
2
NXPI icon
NXP Semiconductors
NXPI
+$1.33B
3
DHR icon
Danaher
DHR
+$1.13B
4
HBI
Hanesbrands
HBI
+$1.06B
5
TMO icon
Thermo Fisher Scientific
TMO
+$845M

Sector Composition

Rank Sector Weight
1 Financials 16.86%
2 Healthcare 16.8%
3 Consumer Discretionary 15.02%
4 Technology 13.29%
5 Industrials 9.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPB icon
1126
Spectrum Brands
SPB
$2.03B
$20.8M ﹤0.01%
170,313
-1,812
-1% -$231K
PBYI icon
1127
Puma Biotechnology
PBYI
$459M
$20.8M ﹤0.01%
678,435
-253,039
-27% -$10.9M
BPMC
1128
DELISTED
Blueprint Medicines
BPMC
$20.7M ﹤0.01%
739,502
+386,308
+109% +$11.6M
EMN icon
1129
Eastman Chemical
EMN
$8.29B
$20.7M ﹤0.01%
275,582
+80
+0% +$5.78K
PEGA icon
1130
Pegasystems
PEGA
$5.15B
$20.7M ﹤0.01%
1,150,200
+3,160
+0.3% +$52.8K
MAA icon
1131
Mid-America Apartment Communities
MAA
$15.4B
$20.6M ﹤0.01%
210,798
+172,442
+450% +$15.9M
SCG
1132
DELISTED
Scana
SCG
$20.6M ﹤0.01%
281,593
+100
+0% +$7.14K
PHX
1133
DELISTED
PHX Minerals
PHX
$20.6M ﹤0.01%
872,794
+1,244
+0.1% +$26.5K
RHI icon
1134
Robert Half
RHI
$4.25B
$20.3M ﹤0.01%
416,643
+13,200
+3% +$565K
TAL icon
1135
TAL Education Group
TAL
$6.58B
$20.3M ﹤0.01%
1,737,900
-2,183,574
-56% -$26.7M
MORE
1136
DELISTED
Monogram Residential Trust, Inc.
MORE
$20.3M ﹤0.01%
1,877,654
+300,519
+19% +$3.16M
PDCE
1137
DELISTED
PDC Energy, Inc.
PDCE
$20.3M ﹤0.01%
279,857
+8,120
+3% +$559K
WYNN icon
1138
Wynn Resorts
WYNN
$10.6B
$20.2M ﹤0.01%
233,751
+1,200
+0.5% +$112K
AGU
1139
DELISTED
Agrium
AGU
$20.2M ﹤0.01%
201,026
+197,026
+4,926% +$19M
FRTA
1140
DELISTED
Forterra, Inc
FRTA
$20.2M ﹤0.01%
+932,291
New +$17.6M
WU icon
1141
Western Union
WU
$2.34B
$20.2M ﹤0.01%
928,519
-14,120
-1% -$293K
MAS icon
1142
Masco
MAS
$14.7B
$20.1M ﹤0.01%
634,639
+1,900
+0.3% +$60.9K
BKH icon
1143
Black Hills Corp
BKH
$5.58B
$20M ﹤0.01%
326,377
-74,369
-19% -$4.44M
MGP
1144
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
$19.8M ﹤0.01%
780,908
+84,109
+12% +$2.1M
AGFS
1145
DELISTED
AgroFresh Solutions Inc
AGFS
$19.7M ﹤0.01%
7,445,908
POLY
1146
DELISTED
Plantronics, Inc.
POLY
$19.6M ﹤0.01%
357,760
+10,500
+3% +$549K
TTI icon
1147
TETRA Technologies
TTI
$1.29B
$19.5M ﹤0.01%
3,891,360
+2,890,500
+289% +$15.6M
CLVS
1148
DELISTED
Clovis Oncology, Inc.
CLVS
$19.5M ﹤0.01%
439,406
-843,388
-66% -$29.7M
NUVA
1149
DELISTED
NuVasive, Inc.
NUVA
$19.4M ﹤0.01%
288,647
+270,752
+1,513% +$17.5M
UNM icon
1150
Unum
UNM
$14.5B
$19.4M ﹤0.01%
441,438

Similar funds

T. Rowe Price Associates's Q4 2016 Portfolio in Review

As of Q4 2016, T. Rowe Price Associates held 2,620 positions worth $504B, up 1.2% from $498B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

T. Rowe Price Associates's Q4 2016 filing shows 96 new, 950 increased, 1,023 reduced and 72 closed positions. Its largest new stake was Adient: 10,357,941 shares worth $607M. The largest sale was Netsuite Inc, an estimated $1.59B.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q4 2016 buy was Adient: 10,357,941 shares worth $607M.
  • T. Rowe Price Associates added most to Wells Fargo in Q4 2016, an estimated $1.31B increase.
  • T. Rowe Price Associates's biggest Q4 2016 reduction was NXP Semiconductors, cutting an estimated $1.33B.
  • T. Rowe Price Associates fully exited Netsuite Inc in Q4 2016, selling an estimated $1.59B.
  • T. Rowe Price Associates's ten largest holdings make up 16% of its $504B portfolio in Q4 2016.
  • T. Rowe Price Associates opened 96 new positions and closed 72 in Q4 2016.
  • T. Rowe Price Associates's portfolio value rose 1.2% quarter-over-quarter to $504B.

Based on T. Rowe Price Associates's 13F filing for Q4 2016, filed 14 Feb 2017.